After nearly a decade of almost year-over-year increases in overdose deaths, the tide may finally be turning in Philadelphia.

A new study by the Substance Abuse and Mental Health Services Administration, a branch of the US Department of Health and ...

New research links emergency department opioid prescriptions to small increases in future opioid use and hospitalisations ...

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.